Catalyst Wire Dossier Catalyst Wire Dossier

Flufirvitide-3

· Autoimmune Technologies, LLC
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Flufirvitide-3, covering 2012-01-16 to 2015-03-11. Get the full timeline:

Most recent: Clinical Trial Update: Safety, Tolerability, and PK of Escalating Doses of Flufirvitide-3 Dry Powder for Inhalation in Healthy Subjects [Phase 1]

See pricing